- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Watkins Glen Today
By the People, for the People
Schuyler County to Consider $97.6M Opioid Settlement
County legislature to vote on joining national agreement with pharmaceutical distributors.
Apr. 9, 2026 at 3:10am
Got story updates? Submit your updates here. ›
Schuyler County's pursuit of opioid settlements aims to fund critical public health programs and support those affected by the crisis.Watkins Glen TodayThe Schuyler County Legislature will review and consider a resolution authorizing the county's participation in a new $97.6 million national opioid settlement at its meeting on Monday, April 13, 2026. The proposed agreement would resolve the county's claims against six regional pharmaceutical distributors, allowing litigation against remaining defendants to continue.
Why it matters
Schuyler County has been actively pursuing legal action against opioid manufacturers and distributors since 2017, seeking damages to fund prevention, treatment and recovery programs in the community. This proposed settlement represents another step in holding companies accountable and securing resources to combat the devastating impacts of the opioid crisis.
The details
Under the proposed agreement, the six pharmaceutical distributor defendants will collectively pay approximately $97.6 million nationwide to support opioid abatement efforts. Each participating municipality, including Schuyler County, will receive a one-time payment, with the specific amount allocated to Schuyler County still being calculated based on a national formula. The funds would be used for approved opioid abatement strategies, including prevention programs, treatment services, naloxone distribution, and support for vulnerable populations affected by opioid addiction.
- The Schuyler County Legislature will review and consider the resolution at its meeting on Monday, April 13, 2026.
- The county's Management and Finance Committee approved the measure on March 23, 2026, and the Legislative Resolution Review Committee approved it on April 8, 2026.
The players
Schuyler County Legislature
The governing body of Schuyler County, New York, which will vote on the proposed opioid settlement resolution.
Steven Getman
The Schuyler County Attorney who will finalize the county's participation in the settlement if approved.
Shawn Rosno
The Schuyler County Administrator who emphasized the importance of continued investment in public health efforts to combat the opioid crisis.
Remnant Defendants
The six regional pharmaceutical distributors that would collectively pay $97.6 million nationwide as part of the proposed settlement.
What they’re saying
“This proposed settlement represents another step forward in holding opioid distributors accountable while delivering meaningful resources to our community.”
— Steven Getman, Schuyler County Attorney
“Schuyler County has remained committed to addressing the opioid crisis through litigation and collaboration. Participation in this settlement will help strengthen our ability to fund prevention, treatment and recovery programs that serve our residents at no additional costs to our taxpayers.”
— Shawn Rosno, Schuyler County Administrator
What’s next
The Schuyler County Legislature will vote on the resolution authorizing participation in the $97.6 million opioid settlement at its meeting on Monday, April 13, 2026.
The takeaway
This proposed settlement represents a significant step in Schuyler County's ongoing efforts to hold pharmaceutical companies accountable for their role in the opioid crisis and secure funding for critical prevention, treatment, and recovery programs that will directly benefit the local community.

